Acasti Pharma to Showcase at the Cambridge Healthtech Institute and the BioPharmaceutical Strategy Series

LAVAL, Quebec, April 14, 2010 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX-V:NTB) announces that Acasti Pharma Inc. ("Acasti") is a proud sponsor and presenter at the 7th Annual Alliance Management congress and the 2nd Annual Combination Drug Therapies Conference, both organized by the Cambridge Healthtech Institute (CHI) and the BioPharmaceutical Strategy Series to be held April 13-14 in Philadelphia, PA. Acasti will present its unique positioning in the field of Cardiometabolic disorders and its action plan for successful collaboration with worldwide pharmaceutical industry leaders and its strategy for implementation.